DUXAP8 and colorectal carcinoma: The lncRNA derivative of DUXAP8 in CRC interacts with EZH2 and H3K27me3 in the E‐cadherin promoter region, suppressing E‐cadherin expression and affecting cell proliferation, epithelial‐mesenchymal transition (EMT), and apoptosis [11].